NCT00040651View on ClinicalTrials.gov

Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
SclerodermaSystemic Sclerosis
Interventions
DRUG

Fludarabine

DRUG

Cyclophosphamide

DRUG

Thymoglobulin

PROCEDURE

Leukapheresis

PROCEDURE

Self bone marrow transplant

Trial Locations (1)

15232

UPMC Hillman Cancer Center, Pittsburgh

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

collaborator

Amgen

INDUSTRY

collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH